- Home
- SABS vs SMSI Comparison
SABS vs SMSI Comparison
Compare SABS & SMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABS
- SMSI
- Stock Information
- Founded
- SABS 2014
- SMSI 1982
- Country
- SABS United States
- SMSI United States
- Employees
- SABS N/A
- SMSI N/A
- Industry
- SABS Biotechnology: Pharmaceutical Preparations
- SMSI Computer Software: Prepackaged Software
- Sector
- SABS Health Care
- SMSI Technology
- Exchange
- SABS Nasdaq
- SMSI Nasdaq
- Market Cap
- SABS 15.8M
- SMSI 16.7M
- IPO Year
- SABS N/A
- SMSI 1995
- Fundamental
- Price
- SABS $2.64
- SMSI $1.04
- Analyst Decision
- SABS Strong Buy
- SMSI Strong Buy
- Analyst Count
- SABS 5
- SMSI 1
- Target Price
- SABS $11.80
- SMSI $5.00
- AVG Volume (30 Days)
- SABS 35.3K
- SMSI 212.3K
- Earning Date
- SABS 08-07-2025
- SMSI 07-31-2025
- Dividend Yield
- SABS N/A
- SMSI N/A
- EPS Growth
- SABS N/A
- SMSI N/A
- EPS
- SABS N/A
- SMSI N/A
- Revenue
- SABS $377,835.00
- SMSI $19,378,000.00
- Revenue This Year
- SABS N/A
- SMSI $10.12
- Revenue Next Year
- SABS N/A
- SMSI $63.12
- P/E Ratio
- SABS N/A
- SMSI N/A
- Revenue Growth
- SABS N/A
- SMSI N/A
- 52 Week Low
- SABS $1.00
- SMSI $0.52
- 52 Week High
- SABS $5.01
- SMSI $2.57
- Technical
- Relative Strength Index (RSI)
- SABS 77.22
- SMSI 65.88
- Support Level
- SABS $1.72
- SMSI $0.82
- Resistance Level
- SABS $2.72
- SMSI $0.95
- Average True Range (ATR)
- SABS 0.19
- SMSI 0.07
- MACD
- SABS 0.10
- SMSI 0.01
- Stochastic Oscillator
- SABS 91.89
- SMSI 83.05
About SABS SAB Biotherapeutics Inc.
SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.
About SMSI Smith Micro Software Inc.
Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.